An autopsy case of bronchiolitis obliterans as a previously unrecognized adverse event of afatinib treatment
- 27 October 2016
- journal article
- case report
- Published by Elsevier in Respiratory Investigation
- Vol. 55 (1) , 58-62
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancerLung Cancer, 2015
- Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trialsThe Lancet Oncology, 2015
- Loss of Basal Cells Precedes Bronchiolitis Obliterans–Like Pathological Changes in a Murine Model of Chlorine Gas InhalationAmerican Journal of Respiratory Cell and Molecular Biology, 2013
- Severe Airway Epithelial Injury, Aberrant Repair and Bronchiolitis Obliterans Develops after Diacetyl Instillation in RatsPLOS ONE, 2011